0001127602-15-029991.txt : 20151102
0001127602-15-029991.hdr.sgml : 20151102
20151102184637
ACCESSION NUMBER: 0001127602-15-029991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151030
FILED AS OF DATE: 20151102
DATE AS OF CHANGE: 20151102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SENSIENT TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000310142
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 390561070
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 EAST WISCONSIN AVENUE
CITY: MILWAUKEE
STATE: WI
ZIP: 53202
BUSINESS PHONE: 4142716755
MAIL ADDRESS:
STREET 1: PO BOX 737
CITY: MILWAUKEE
STATE: WI
ZIP: 53201
FORMER COMPANY:
FORMER CONFORMED NAME: UNIVERSAL FOODS CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLYDESDALE FERGUS M
CENTRAL INDEX KEY: 0001200339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07626
FILM NUMBER: 151191866
MAIL ADDRESS:
STREET 1: 777 E WISCONSIN AVE
CITY: MILWAUKEE
STATE: WI
ZIP: 53202
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-10-30
0000310142
SENSIENT TECHNOLOGIES CORP
SXT
0001200339
CLYDESDALE FERGUS M
777 EAST WISCONSIN AVENUE
MILWAUKEE
WI
53202
1
Common Stock
2015-10-30
4
M
0
2000
20.25
A
23032.906
D
Common Stock
2015-10-30
4
S
0
2000
65.0145
D
21032.906
D
Stock Options (Right to Buy)
20.25
2015-10-30
4
M
0
2000
0
D
2007-05-01
2016-05-01
Common Stock
2000
0
D
Stock Options (Right to Buy)
26.12
2008-05-01
2017-05-01
Common Stock
2000
2000
D
Stock Options (Right to Buy)
30.07
2009-05-01
2018-05-01
Common Stock
2000
2000
D
Exercise of in-the-money stock option that would otherwise expire on 5/1/2016, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
Includes shares of restricted stock held under Issuer's 2002 Non-Employee Director Stock Plan and 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $65.00 to $65.09. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.
/s/ John L. Hammond, Attorney-in-Fact for Dr. Clydesdale
2015-11-02